Anti-infective drugs are that work to prevent or treat infections. Antibiotics, antifungals, anthelmintics, antimalarials, antiprotozoals, antituberculosis agents, and antivirals are included in this category.
MARKET DYNAMICS
Factors driving the growth of the anti-infective drugs market are the growing prevalence of infectious diseases worldwide, coupled with rising research and development activities for the development of new drugs. However, the high cost of anti-infective drugs and poor reimbursement policies is expected to hamper the growth of the market. Moreover, increasing approvals for new anti-infective drugs in nutraceutical industries and growing awareness about infectious diseases among the population are anticipated to boost the market growth.
MARKET SCOPE
The "Anti-Infective Drugs Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of anti-infective drugs market with detailed market segmentation by drug type, route of administration, and indication. The anti-infective drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in anti-infective drugs market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The anti-infective drugs market is segmented on the basis of drug type, route of administration, and indication. Based on drug type, the market is segmented as antibiotics, antivirals, antifungals, and others. On the basis of route of administration, the market is categorized as HIV infections, pneumonia, hepatitis, herpes simplex virus, influenza, and others. On the basis of indication, the market is categorized as oral, topical, and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the anti-infective drugs market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The anti-infective drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting anti-infective drugs market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely, North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the anti-infective drugs market in these regions.
MARKET PLAYERS
The report covers key developments in the anti-infective drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from anti-infective drugs market are anticipated to have lucrative growth opportunities in the future with the rising demand for anti-infective drugs in the global market. Below mentioned is the list of few companies engaged in the anti-infective drugs market.
The report also includes the profiles of key players in anti-infective drugs market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Merck & Co., Inc
- F. Hoffmann-La Roche Ltd
- Pfizer Inc
- Johnson & Johnson Services, Inc
- GlaxoSmithKline plc
- Hetero
- Mylan N.V.
- Aurobindo Pharma
- Cipla Inc
- Laurus Labs Ltd
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.